Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23012326 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant
Conditions: AML;   CML;   MDS
Interventions: Drug: CYT107 - Recombinant glycosylated human interleukin 7.;   Drug: rhIL-7 (CYT107)

Study has passed its completion date and status has not been verified in more than two years.